🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8012493

Malaria vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8012730

Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8012490

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8012699

Recombinant antigens for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008266

Methods of treating cancer using immunostimulatory oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008316

Azonafide derived tumor and cancer targeting compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003112

Meningococcal and pneumococcal conjugate vaccine and method of using same

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003764

Folliculin-specific antibodies and methods of detection

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003629

21-substituted progesterone derivatives as new antiprogestational agents

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003406

Methods for detecting attention-deficit/hyperactivity disorder

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999077

IRTA2 antibodies and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998682

Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998736

Adoptive immunotherapy with enhanced T lymphocyte survival

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999001

Antiviral compounds and methods of using thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999007

Buffer solutions having selective bactericidal activity against gram negative bacteria and

United Therapeutics Corporation · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999071

Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999074

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7993046

Flexible light-emitting apparatus

United Lighting Opto-Electronic Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7993921

Cell cycle regulation and differentiation

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7993919

Method of inducing memory B cell development and terminal differentiation

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7993857

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7989501

Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7988958

Enterococcus and Streptococcus strains and bacteriocins

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7988971

Human monoclonal antibodies against Hendra and Nipah viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted